Journal
BRAIN
Volume 138, Issue -, Pages 3685-3698Publisher
OXFORD UNIV PRESS
DOI: 10.1093/brain/awv288
Keywords
Alzheimer's disease; microglia; amyloid imaging; neuropathology; dementia
Categories
Funding
- National Institute for Health Research (NIHR) Imperial Biomedical Research Centre
- Medical Research Council
- Alzheimer's Research UK
- Higher Education Funding Council for England (HEFCE)
- Alzheimer's Drug Discovery Foundation
- Alzheimer's Society, UK
- Novo Nordisk
- GE Healthcare
- Alzheimer's Research Trust
- Alzheimers Research UK [ARUK-PG2014-20] Funding Source: researchfish
- Medical Research Council [MC_U120036861, G1100810] Funding Source: researchfish
- MRC [G1100810, MC_U120036861] Funding Source: UKRI
Ask authors/readers for more resources
Amyloid deposition, tangle formation, neuroinflammation and neuronal dysfunction are pathological processes involved in Alzheimer's disease. However, the relative role of these processes in driving disease progression is still unclear. The aim of this positron emission tomography study was to: (i) investigate longitudinal changes of microglial activation, amyloid and glucose metabolism; and (ii) assess the temporospatial relationship between these three processes in Alzheimer's disease. A group of eight patients with a diagnosis of Alzheimer's disease (66 +/- 4.8 years) and 14 healthy controls (65 +/- 5.5 years) underwent T-1 and T-2 magnetic resonance imaging, along with C-11-(R)-PK11195, C-11-Pittsburgh compound B and F-18-fluorodeoxyglucose positron emission tomography scans for microglial activation, amyloid deposition and glucose metabolism. All patients were followed-up with repeated magnetic resonance imaging and three positron emission tomography scans after 16 months. Parametric maps were interrogated using region of interest analysis, Statistical Parametric Mapping, and between-group correlation analysis at voxel-level using Biological Parametric Mapping. At baseline, patients with Alzheimer's disease showed significantly increased microglial activation compared to the control subjects. During follow-up, for the first time, we found that while there is a progressive reduction of glucose metabolism, there was a longitudinal increase of microglial activation in the majority of the patients with Alzheimer's disease. Voxel-wise correlation analysis revealed that microglial activation in patients with Alzheimer's disease was positively correlated with amyloid deposition and inversely correlated with regional cerebral metabolic rate at voxel level over time. Even though one of the limitations of this study is the lack of longitudinal follow-up of healthy control subjects, this study demonstrates that there is persistent neuroinflammation throughout the Alzheimer's disease process with associated synaptic dysfunction and reduced glucose metabolism. Voxel-wise correlation analysis suggests that neuroinflammation is associated with localized amyloid deposition and glucose metabolism over time, however, the level of inflammation could also occur independently of amyloid pathology, especially in the later stages of Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available